Why Aren’t There Better Cancer Drugs? Scientists May Have Picked the Wrong Targets - The New York Times

Why Aren’t There Better Cancer Drugs? Scientists May Have Picked the Wrong Targets  The New York Times

Drugs can stop cancer cells if they attack the right proteins. But many of these targets were chosen with dated, imprecise technology, a new study suggests.